NCT02502604 Cognitive Training Program for Individuals With Depression and Post-Traumatic Stress Disorder Status COMPLETED Phase NA
NCT02480400 The Effect of Patient and Investigator Expectation on the Efficacy of Escitalopram in the Treatment Depression Status COMPLETED Phase NA
NCT02479464 Clinical Impact of the Antidepressant Pharmacogenomic Algorithm in an Outpatient Therapy-based Clinical Setting Status COMPLETED Phase NA
NCT02476058 A Safety, Efficacy and Biomarker Study of JNJ-42847922 in Participants With Major Depressive Disorder Status COMPLETED Phase PHASE1
NCT02473783 The Serotonin Transporter Availability for Prognosing Major Depressive Disorder (MDD) Treatment and Detecting MDD Status COMPLETED Phase PHASE2
NCT02470026 Noradrenergic Activity, Cognition and Major Depressive Disorder Status COMPLETED Phase NA
NCT02461927 Ketamine for the Rapid Treatment of Major Depressive Disorder and Alcohol Use Disorder Status COMPLETED Phase PHASE1/PHASE2
NCT02460666 Brain Connectivity and Response to Tai Chi in Geriatric Depression Status COMPLETED Phase NA
NCT02458690 eIMPACT Trial: Modernized Collaborative Care to Reduce the Excess CVD Risk of Older Depressed Patients Status COMPLETED Phase PHASE2
NCT02454426 Vortioxetine in Patients With Major Depressive Disorder and Coronary Artery Disease Status WITHDRAWN Phase EARLY_PHASE1
NCT02443584 Pharmacogenetic Testing on an Outpatient Population With a Depression Diagnosis Status COMPLETED Phase NA
NCT02440815 Multimodal MRI Characteristics of Psychotherapy Response in Late Life Depression Status COMPLETED Phase NA
NCT02436239 A Study of Vilazodone in Pediatric Patients With Major Depressive Disorder Status COMPLETED Phase PHASE3